May maybes as Spanish in prepares to pay back d€bt €Billions to pharma
This article was originally published in Scrip
There is soon to be some relief for pharmaceutical companies in Spain that have been struggling to recover hospital debts related to drug purchases totalling €6.3 billion. A €35 billion "liquidity injection" from the central Spanish government should see regional and local authorities start to pay back providers, said the treasury this week. However, it is far from clear that the financial jab in the arm provides any comfort for the pharma industry beyond the immediate future.
You may also be interested in...
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.
In an exclusive interview with the Pink Sheet, senior NICE director Meindert Boysen reveals the best advice he ever received and how companies whose products are under review can improve their chances of success.
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.